Drugs / PF-07915048
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05227001 | Apr 2022 → Aug 2023 | influenza | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07915048 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05227001 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT05227001 ↗ |